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ORIGINAL RESEARCH
LOW CORONARY PERFUSION PRESSURE IS
ASSOCIATED WITH ENDOCARDIAL FIBROSIS IN A
RAT MODEL OF VOLUME OVERLOAD CARDIAC
HYPERTROPHY
Maria Carolina Guido, Márcia Kiyomi Koike and Clovis de Carvalho Frimm
GUIDO MC et al. Low coronary perfusion pressure is associated with endocardial fibrosis in a rat model of volume overload
cardiac hypertrophy. Rev. Hosp. Clín. Fac. Med. S. Paulo 59(4):228-235, 2004.
Left ventricular hypertrophy following volume overload is regarded as an example of cardiac remodeling without
increased fibrosis accumulation. However, infarction is associated with increased fibrosis within the noninfarcted,
hypertrophied myocardium, particularly in the subendocardial regions. It is conceivable to suppose that, as also occurs
postinfarction, low coronary driving pressure may also interfere with accumulation of myocardial fibrosis following aortocaval
fistula.
PURPOSE: To investigate the role of acute hemodynamic changes in subsequent deposition of cardiac fibrosis in
response to aortocaval fistula.
METHOD: Aortocaval fistula were created in 4 groups of Wistar rats that were followed over 4 and 8 weeks: aortocaval
fistula 4 and aortocaval fistula 8 (10 rats each) and their respective controls (sham-operated controls - Sh), Sh4 and Sh8 (8
rats each). Hemodynamic measurements were performed 1 week after surgery. Hypertrophy and fibrosis were quantified by
myocyte diameter and collagen volume fraction at the end of follow up.
RESULT: Compared with Sh4 and Sh8, pulse pressure, left ventricular end-diastolic pressure, and +dP/dt were higher in
aortocaval fistula 4 and aortocaval fistula 8, but –dP/dt was
 
similar. Coronary driving pressure (mm Hg), used as an estimate of
perfusion pressure, was lower in aortocaval fistula 8 (52.6 ± 4.1) than in Sh8 (100.8 ± 1.3), but comparable between aortocaval
fistula 4 (50.0 ± 8.9) and Sh4 (84.8 ± 2.3). Myocyte diameter was greater in aortocaval fistula 8, whereas interstitial and
subendocardial fibrosis were greater in aortocaval fistula 4 and aortocaval fistula 8. Coronary driving pressure correlated
inversely and independently with subendocardial fibrosis (r2 = .86, P <.001), whereas left ventricular systolic pressure (r2 = 0.73,
P = .004) and end-diastolic pressure (r2 = 0.55, P = 012) correlated positively and independently with interstitial fibrosis.
CONCLUSION: Coronary driving pressure falls and ventricular pressures increase early after aortocaval fistula and are
associated with subsequent myocardial fibrosis deposition.
KEY WORDS: Myocardial fibrosis. Aortocaval fistula. Coronary driving pressure. Volume overload. Cardiac
remodeling.
An increase in myocyte volume ac-
companied by an expansion of the ex-
tracellular matrix characterize the de-
velopment of myocardial hypertrophy
in response to cardiac overload.1,2,3 The
positive effect is the preservation of
cardiac performance by preventing an
increase in myocardial oxygen con-
sumption.4,5,6
Although initially beneficial,
hypertrophy may ultimately result in
cardiac failure.1,7,8 One of the potential
mechanisms involved is the advent of
myocardial ischemia, which may fol-
low a disproportionate growth of
myocytes relative to coronary ves-
sels.9,10,11 Recurrent ischemic episodes
predictably result in myocyte necrosis
and scar formation.12,13,14
In different animal models of car-
3205.p65 15/10/2004, 15:36228
229
REV. HOSP. CLÍN. FAC. MED. S. PAULO 59(5):228-235, 2004 Low coronary perfusion pressure is associated with endocardial fibrosis
Guido MC et al.
diac hypertrophy, it has been repeatedly
documented that the collagen volume
fraction (CVF) increases.15,16,17,18 Two
main forms of fibrillar collagen accumu-
lation are currently acknowledged: re-
active and reparative fibrosis.19,20,21,22
Reactive interstitial fibrosis follows the
development of pressure overload
hypertrophy, in particular, and is char-
acterized by an increased accumulation
of collagen fibers intermingled among
myocytes.16,23 Reparative fibrosis results
from myocyte loss and represents
wound healing scarring, such as occurs
following myocardial infarction.12,15
In eccentric hypertrophic response
to volume overload, myocyte growth
and fibrillar collagen accumulation
appear to develop in a proportional
manner.24-26 However, increased fibro-
sis has recently been reported in cases
of volume overload.10,11,27,28 In infarc-
tion, the development of interstitial
and subendocardial (SE) fibrosis
within noninfarcted myocardium has
been recognized.12,29,30 In this case, SE
fibrosis appears to represent a repair
process in response to persistent
ischemia in this region, since the coro-
nary driving pressure (CDP) has been
documented to be low during the early
phases after infarction12.
It is conceivable to suppose that a
similar mechanism might have a role in
collagen fiber accumulation in volume
overload hypertrophy. If the initial
hemodynamic burden affects the CDP,
as already demonstrated for large
infarcts,12 SE fibrosis is likely to super-
vene. Furthermore, interstitial fibrosis
might also follow if, in addition to vol-
ume overload, afterload were increased
during hypertrophy development.
In experimental cardiac hypertro-
phy, hemodynamic monitoring during
surgical procedures is rarely per-
formed. Consequently, the effects of
acute hemodynamic changes on sub-
sequent myocardial remodeling are
currently undetermined.
The aim of the present study is to
investigate in a experimental model of
volume overload cardiac hypertrophy:
1) whether or not there is increased car-
diac collagen accumulation, 2) the dis-
tribution and type of fibrosis, and 3)
the potential role of acute
hemodynamic changes in the subse-




Wistar rats weighing 280 to 350 g
were used. All procedures were carried
out in accordance with the norms of
the Brazilian College of Animal Ex-
periments and conformed to the
“Guide for the Care and Use of Labo-
ratory Animals”. Our Institutional Ethi-
cal Committee approved the protocol
(CAPPesq, 160/02).
Four groups of animals with surgi-
cally created aortocaval fistula (ACF)
were constituted: ACF4 and ACF8, 10
rats each, and their respective sham-
operated controls (Sh), Sh4 and Sh8,
8 rats each, followed over 4 and 8
weeks, respectively.
Experimental model
Surgical procedures were carried
out using a modified technique that
has been previously described31,32. Un-
der 10% chloral hydrate anesthesia
(300 mg/kg, intraperitoneally)33 and
positive pressure ventilation (Harvard
- Rodent ventilator – Model 683 -
South Natick, Massachusetts, EUA), a
median laparotomy was performed,
and the abdominal aorta and the infe-
rior vena cava were identified and iso-
lated from neighboring structures un-
derneath the emergence of the renal ar-
teries. Arterial and venous blood flow
was briefly interrupted with the aid of
vascular clamps to permit the insertion
of an 18-gauge needle into the aorta.
The needle was carefully advanced,
and the posterior aortic wall was punc-
tured 3 to 4 times to the inside of the
vena cava. After removing the needle,
homeostasis was conducted with local
application of super glue. The abdomi-
nal wall was closed and the animals
returned to their cages after full recov-
ery.
The mortality rate was 8% imme-
diately, 29% 48 hours after surgery,
and 23% during long-term follow up.
Fistula permeability was assessed daily
with a pediatric stethoscope.
Hemodynamic measurements
One week after surgery, surviving
rats were anesthetized again and sub-
mitted to simultaneous systemic and
cardiac hemodynamic measurements
(hemodynamics—phase 1). Briefly, a
0.05 mm polyvinyl chloride catheter
was inserted through the right carotid
artery into the ascending aorta and ad-
vanced into the left ventricle (LV). An-
other catheter was inserted through the
jugular vein into the superior vena
cava and advanced into the right
atrium. Also, a 0.01 mm catheter was
introduced through the left femoral ar-
tery and advanced into the descending
abdominal aorta. The catheters were
connected to pressure transducers and
coupled with a calibrated pre-amplifier
(General Purpose Amplifier 4 - model
2, Stemtech Inc. WI, USA). Pressure
tracings were recorded and analyzed
using a computerized system proces-
sor (Windaq - AT/Codas, Dataq Instru-
ments Inc., OH, USA).
The following parameters were
evaluated: systemic systolic arterial
pressure (mm Hg) and systemic
diastolic arterial pressure (mm Hg), LV
systolic pressure (mm Hg), LV end-
diastolic pressure (mm Hg), and right
mean atrial pressure (mm Hg). In addi-
tion, the positive and the negative de-
rivatives of LV pressure with respect to
time (+dP/dt, mm Hg·s-1 and –dP/dt ,
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mm Hg·s-1) were obtained as measures
of LV systolic and diastolic function,
respectively.
Pulse pressure (mm Hg) was calcu-
lated as the difference between sys-
temic systolic arterial pressure and
diastolic arterial pressure and used as
a measure of fistula size.
CDP (mm Hg) calculated by the
difference between systemic diastolic
arterial pressure and LV end-diastolic
pressure was used as an estimate of
myocardial perfusion pressure.34
After 4 and 8 weeks of follow up,
before sacrifice, rats were again anes-
thetized, and the femoral artery was
catheterized for new systemic systolic
arterial pressure, diastolic arterial pres-
sure, and pulse pressure determinations
(hemodynamics—phase 2).
All measurements corresponded to
the mean value of each hemodynamic
parameter continuously recorded dur-
ing a 10-minute period after stabili-
zation of the pressure curves.
Anatomic and morphometric study
The animals were sacrificed using
a 100 mM CdCl2 solution and were
perfusion-fixed with 10% formalin un-
der a perfusion pressure corresponding
to the systemic diastolic arterial pres-
sure in vivo. The heart, lungs, and liver
were removed, cleaned, and weighed.
The dry weight of the lungs and liver
were used for calculating the percent-
age of water content in each tissue,
which was used as an estimate of con-
gestive heart failure. After determining
heart / body weight (g·kg-1), the right
and the left atrium were carefully
trimmed out and weighed separately.
A 1 to 2 mm coronal slice of the
heart, including both ventricles, was
cut at the equatorial plane to obtain
7 µm thick paraffin-embedded tissue
sections. After being stained with
hematoxylin and eosin (HE) and
picrosirius red,35 these sections under-
went morphometric analysis using an
image analysis system (Leica Q500 iW,
Leica Imaging Systems ltd., Cam-
bridge, UK).
At first, each HE tissue section was
visualized under a macro lens (28 mm,
Tamron, Japan) to permit the determi-
nation of LV wall thickness and LV
cavity dimension, both expressed as
tissue areas (µm2). Subsequently, LV
myocyte hypertrophy was estimated
under a 100x microscopic objective by
measuring myocyte transversal diam-
eter around the nucleus (µm).
Fibrillar collagen was identified in
the picrosirius red-stained sections by
its red color. Under a 40x microscopic
objective, an estimate of CVF was de-
termined to be the mean percentage of
red-stained connective tissue areas per
total myocardial area in each micro-
scopic field (%). The CVF was ad-
dressed separately in 2 distinct re-
gions: the inner third of the LV, corre-
sponding to the subendocardium, and
the medium third of the interventricu-
lar septum. An average of 15 to 20
fields was examined in each of these
2 myocardial regions.
Perivascular collagen (%) was cal-
culated separately as the ratio of
picrosirius red-positive stained areas
around microvessels to luminal perim-
eter. Only 50 to 200 µm arterioles with
major to minor diameter ratio <0.60
were computed.
Statistical Analysis
Variables are expressed as mean ±
SE. One-way analysis of variance or
Kruskal-Wallis on ranks were used for
intergroup comparisons of data. Post
hoc comparisons were performed using
Bonferroni’s and Dunn’s methods.
Pearson’s correlation coefficient was
used to test the association between
hemodynamics—phase 1 data and fi-
brillar collagen measures.
Multiple linear forward stepwise
regression analysis was performed to
identify which among the hemody-
namic variables could predict subse-
quent fibrosis.
A P <.05 value was considered sta-
tistically significant.
Data were computed in Excel
spreadsheets (Excel, 1997 Microsoft,
USA) for subsequent analysis using
Sigma Stat software (Sigma Stat 1994,
Jandel Scientific, USA).
RESULTS
Hemodynamics – Phase 1
Table 1 summarizes the hemody-
namic data obtained 1 week after the
surgical experiment in the 4 groups
studied: Sh4, ACF4, Sh8, and ACF8.
Except for systemic diastolic arterial
Table 1 - Hemodynamic data obtained at one week following aortocaval fistula
creation (hemodynamics—phase 1) of groups Sh4, ACF4, Sh8, and ACF8.
Sh4 ACF4 Sh8 ACF8 P
N 8 10 8 10
SAP (mm Hg) 115.3 ± 2.7 104.8 ± 5.9* 123.3 ± 1.0 104.0 ± 3.7* .001
DAP (mm Hg) 91.8 ± 2.3 68.0 ± 7.0 108.0 ± 1.1 66.6 ± 3.8* <.001
PP (mm Hg) 23.5 ± 2 36.8 ± 2.6* 15.3 ± 1.4 37.4±3.3* <.001
LVSP (mm Hg) 113.1 ± 3.3 124.1 ± 6.2 117.6 ± 1.8 150.2 ± 5.9* <.001
LVEDP (mm Hg) 7.0 ± 0.1 18.1 ± 3.4* 7.2 ± 0.3 14.0 ± 1.5* <.001
+dP/dt (103 mm Hg·s-1) 4.0 ± 0.2 5.8 ± 0.6* 3.9 ± 0.1 6.2 ± 0.5* <.001
–dP/dt (103 mm Hg·s-1) 3.8 ± 0.2 4.5 ± 0.4 3.9 ± 0.2 4.1 ± 0.5 .530
RAP (mm Hg) 5.3 ± 0.3 8.4 ± 0.6* 5.1 ± 0.2 8.0 ± 1.1* <.001
HR (beats·min-1) 370.0 ± 13.3 348.5 ± 25.1 373.6 ± 7.3 344.4 ± 11.8 .262
SAP, systemic systolic arterial pressure; DAP, systemic diastolic arterial pressure; PP, pulse pressure;
LVSP, left ventricular systolic pressure; LVEDP, left ventricular end-diastolic pressure; +dP/dt,
positive derivative of left ventricular pressure; –dP/dt, negative derivative of left ventricular
pressure; RAP, right mean atrial pressure; HR, heart rate; *, P <.05 ACF vs respective Sh.
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pressure in ACF4, systemic arterial
pressures were statistically lower in
both ACF4 and ACF8 than in their re-
spective Sh controls. Accordingly,
pulse pressure was statistically greater
in ACF than in Sh groups.
Intraventricular pressures showed
higher LV systolic pressure in ACF8
than in Sh8 and higher LV end-
diastolic pressure in ACF4 than in Sh4
and in ACF8 than in Sh8.
LV function showed greater +dP/dt
in both ACF groups than in their re-
spective Sh controls and comparable
–dP/dt.
Right mean atrial pressure was sta-
tistically higher in both ACF than in
Sh, whereas heart rate did not differ.
As for LV perfusion pressure (Fig-
ure 1), CDP was lower in ACF, al-
though this was statistically signifi-
cant only with regards to the compari-
son between ACF8 and Sh8.
Hemodynamics – Phase 2
At the end of follow up (Table 2),
while systemic systolic arterial pres-
sure was comparable between both
ACF4 and ACF8 and their respective
Sh controls, systemic diastolic arterial
pressure was statistically lower. Ac-
cordingly, pulse pressure was signifi-
cantly higher in both ACF groups than
in their Sh controls. Again, heart rate
was comparable among groups.
Anatomy and Morphometry
Table 3 depicts the anatomic and
morphometric data. While initial
weights of rats were comparable in all
groups, final weights were greater in
groups followed over 8 weeks than in
groups followed over 4 weeks.
The percent of water in lungs and
liver as well as the relative total heart
and left atrium weights were not sta-
tistically different among groups.
While relative left atrium weight
did not differ between ACF and Sh
Table 2 - Hemodynamic data obtained at 4 and 8 weeks following aortocaval
fistula creation (hemodynamics—phase 2) of groups Sh4, ACF4, Sh8, and ACF8.
Sh4 ACF4 Sh8 ACF8 P
N 8 1 0 8 1 0
SAP (mm Hg) 125.5 ± 1.9 120.7 ± 7.9 128.8 ± 1.7 116.4 ± 6.1 .414
DAP (mm Hg) 94.3 ± 2.4 71.2 ± 5.5* 94.0 ± 2.1 67.7 ± 5.2* <.001
PP (mm Hg) 31.3 ± 1.6 49.5 ± 5.2* 34.8 ± 2.7 48.7 ± 5.0* .007
HR (beats·min-1) 373.5 ± 12.8 337.0 ± 32.3 386.8 ± 10.7 343.6 ± 20.6 .542
SAP, systemic systolic arterial pressure; DAP, systemic diastolic arterial pressure; PP, pulse
pressure; HR, heart rate; *, P <.05 ACF vs.respective Sh.
Table 3 - Heart and body weights, percent of organ water weight, myocyte diameter,
and collagen volume fraction of groups Sh4, ACF4, Sh8, and ACF8.
Sh4 ACF4 Sh8 ACF8 P
N 8 10 8 1 0
IAW (g) 315.9 ± 7.2 309.2 ± 9.6 297.8 ± 2.6 322.0 ± 6.8 .071
FAW (g) 367.5 ± 11.4 357.0 ± 7.7 414.7 ± 15.3= 421.7 ± 6.3= <.001
% H2OLu 84.1 ± 0.8 82.0 ± 0.6 85.2 ± 1.0 82.2 ± 1.2 .061
% H2OLi 74.6 ± 0.3 72.4 ± 0.8 72.6 ± 0.8 71.2 ± 1.9 .174
HW 5.2 ± 0.2 5.5 ± 0.5 4.3 ± 0.2 5.8 ± 0.7 .07
LAW 0.09 ± 0.01 0.14 ± 0.02 0.11 ± 0.01 0.16 ± 0.02 .059
RAW 0.06 ± 0.01 0.13 ± ±0.02* 0.07 ± 0.01 0.15 ± 0.04 .001
LV WT (µm2) 42.3 ± 3.3 35.7 ± 2.2 51.9 ± 4.3 31.0 ± 2.3* .001
LV CD (µm2) 36.1 ± 6.5 25.4 ± 3.5 37.2 ± 4.2 39.8 ± 8.2 .323
MY φ (µm) 6.7 ± 0.05 9.2 ± 0.26* 6.2 ± 0.07 10.1 ± 0.19* <.001
SE CVF (%) 4.6 ± 0.47 26.7 ± 5.5* 4.0 ± 0.79 25.6 ± 3.5* <.001
IVS CVF (%) 5.5 ± 0.61 13.7 ± 1.4* 4.7 ± 0.61 13.4 ± 1.3* <.001
PVC (%) 13.7 ± 1.3 15.4 ± 1.5 14.2 ± 0.7 16.5 ± 2.9 .834
IAW, initial animal weight; FAW, final animal weight; % H2OLu, percentage of water in lungs; %
H2OLi, percentage of water in liver; HW, relative heart weight; RAW, relative right atrium
weight; LAW, relative left atrium weight; LV WT, left ventricular wall thickness; LV CD, left
ventricular cavity dimension; MY φ, myocyte diameter; SE CVF, subendocardial collagen
volume fraction; IVS CVF, interventricular septum collagen volume fraction; PVC, perivascular
collagen; *, P <.05 ACF vs respective Sh; =, P <.05 8 vs respective 4.
Figure 1 - Left ventricular coronary driving pressure in Sh4, ACF4, Sh8, and ACF8 groups. *,
P <.05 ACF vs respective Sh.
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groups, relative right atrium weight
was statistically greater in ACF4 than
in Sh4.
While LV wall thickness did not
statistically differ between ACF4 and
Sh4 groups, it was lower in ACF8 than
in Sh8. The cavity dimension of the
LV did not differ between ACF and Sh
groups.
At the microscopic level, myocyte
diameter was statistically greater in
both ACF4 and ACF8 than in their re-
spective Sh controls.
Thus, excentric left ventricular
hypertrophy was manifested in ACF8
by larger myocyte diameter and
smaller wall thickness than in Sh8,
with comparable cavity dimension.
As for the extracellular matrix com-
partment, CVF measured within each
of the two regions examined, interven-
tricular septum and SE, was statisti-
cally greater in both ACF groups than
in their respective Sh controls. Perivas-
cular collagen did not differ among
groups.
In Figure 2 is portrayed the hall-
mark of the histological findings found
in ACF rats, represented by LV SE fi-
brosis.
Hemodynamic determinants of left
ventricular fibrosis
Subendocardial fibrosis
The SE fibrosis of hearts examined
8 weeks after experimental surgery
correlated positively with pulse pres-
sure (r = 0.85, P <.001), LV systolic
pressure (r = 0.67, P = .038), and LV
end-diastolic pressure (r = 0.74, P =
.001) measured 1 week after surgery. In
addition, SE fibrosis at 8 weeks corre-
lated inversely with systemic systolic
arterial pressure (r = –0.69, P = .003),
systemic diastolic arterial pressure (r =
–0.91, P <.001), and CDP (r = –0.93,
P <.001).
Among all, only CDP independ-
ently predicted SE fibrosis (r2 = 0.86,
SE = 0.0536, P <.001) at 8 weeks.
Interventricular septum fibrosis
Interstitial fibrosis within interven-
tricular septum of hearts examined 8
weeks after experimental surgery cor-
related positively with LV systolic
pressure (r = 0.74, P = .001), LV end-
diastolic pressure (r = 0.68, P = .004),
and pulse pressure (r = 0.58, P = .018)
measured 1 week after surgery. In ad-
dition, septal fibrosis at 8 weeks cor-
related inversely with systemic systolic
arterial pressure (r = –0.60, P = .014),
systemic diastolic arterial pressure (r =
–0.69, P = .003), and CDP (r = –0.72,
P = .002).
Among all, LV systolic pressure (r2
= 0.73, SE = 0.0377, P = .004) and LV
end-diastolic pressure (r2 = 0.55, SE =
0.1613, P = .012) were predicted inde-
pendently of septal fibrosis.
DISCUSSION
The present study showed dissimi-
lar reductions in systemic systolic and
diastolic arterial pressures, which re-
sulted in an increase in pulse pressure
1 week following experimental
aortocaval fistula in rats. The de-
creased systemic diastolic pressure
corresponds to the characteristic
hemodynamic change found in arterio-
venous shunts and stands for a decrease
in systemic vascular resistance17,18. Ad-
ditionally, LV hemodynamics also
changed. Both LV systolic and end-
diastolic pressures increased, whereas
CDP decreased. Cardiac systolic func-
tion, represented by LV +dP/dt was im-
proved, whereas cardiac diastolic func-
tion, represented by LV –dP/dt was un-
altered.
The small gradient observed be-
tween systemic and LV pressures must
be regarded as a consequence of meas-
uring systolic arterial pressure distally
from the vascular shunt in the present
study.
In contrast with our findings, pre-
vious studies reported reductions of
Figure 2 - Photomicrographs of picrosirius red-stained tissue sections under a 40x magnification
featuring the left ventricular subendocardial region representative of each one of the 4 groups
of rats studied: Sh4, ACF4, Sh8, and ACF8. Subendocardial collagen deposition in hearts of
ACF animals is illustrated by a marked increase in picrosirius red-stained positive areas.
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LV systolic pressure,17,18,36 indicating
the presence of cardiac dysfunction. It
has to be emphasized that
hemodynamic monitoring was per-
formed before sacrifice in most former
studies, when cardiac dysfunction has
had enough time to supervene. Our 1-
week hemodynamic results demon-
strate that diastolic function was pre-
served despite the elevation of LV end-
diastolic pressure. This may be ex-
plained by an enlarged LV dimension
and thus increased preload, which may
have in part contributed to the
hypercontractility found, through the
Starling mechanism. Since morphom-
etry was performed only 4 and 8 weeks
after the hemodynamic measurements,
this premise cannot be definitely af-
firmed based on the present findings.
At the end of the experiment, while
systolic pressure in rats with aortocaval
shunts decreased to values comparable
with their respective controls, diastolic
pressure remained lower as did pulse
pressure. This hemodynamic pattern
indicates that the vascular shunt re-
mained pervious in most ACF rats over
the entire period of observation.
The decrease in CDP may have
contributed to ongoing myocardial
ischemia and necrosis with subsequent
fibrosis repair, ultimately resulting in
cardiac dysfunction. To the best of our
knowledge, this is the first study to
demonstrate in an experimental animal
model of eccentric hypertrophy that
CDP actually falls. It is likely that the
CDP decrease persisted for longer than
1 week, since systemic diastolic pres-
sure remained low until morphometric
studies were performed. It remains to be
demonstrated whether left ventricular
end-diastolic pressure remains elevated.
The advent of cardiac hypertrophy
was best demonstrated by myocyte en-
largement occurring as early as 4 weeks
following aortocaval fistula. Although
the water content of lungs and liver was
not increased, indicating that that overt
heart failure did not occur in these ani-
mals, this does not necessarily mean
that cardiac function was not impaired.
The absence of LV hemodynamic data
before sacrifice precluded an accurate
estimation of cardiac function at the end
of experiment.
Cardiac remodeling at the
nonmyocyte compartment was illus-
trated by a relative increase in fibril-
lar collagen deposition within the in-
terstitial space as well as within the SE
region. Accordingly, 2 types of cardiac
fibrosis deposition were found in hearts
of rats with aortocaval fistulas: reac-
tive interstitial fibrosis and reparative
SE fibrosis.19,37,38 Perivascular fibrosis
was absent.
Although hemodynamics—phase
1 data were not significantly associ-
ated with the presence of myocardial
fibrosis 4 weeks after aortocaval fis-
tula, they correlated significantly with
fibrosis found at 8 weeks. Among all
hemodynamic variables, it was CDP
that independently predicted SE fibro-
sis, whereas LV systolic and end-
diastolic pressures independently pre-
dicted interstitial septal fibrosis. The
association of decreased CDP during
the early phases of hemodynamic de-
rangement following aortocaval fistula
creation with subsequent SE fibrosis
has not been reported before. This fact
suggests that SE fibrosis may conceiv-
ably be the consequence of impaired
coronary perfusion. On the other hand,
interstitial fibrosis appears to be con-
sequence of LV overload. In this re-
gard, the increase in interstitial fibril-
lar collagen presently observed does
not differ from that reported to occur
in different experimental models of
cardiac hypertrophy in response to
afterload increase.16,20
The increase in interstitial myocar-
dial fibrosis in this model of aortocaval
fistula is actually controversial.24,27,28 It
is conceivable to speculate that while
LV hypertrophy is physiological and
associated with preserved ventricular
function, interstitial collagen remains
relatively unchanged. In advanced
stages characterized by cardiac dys-
function, it may be that collagen accu-
mulates within the interstitial space. To
confirm this hypothesis, hemodynamic
measurements are to be repeated before
the sacrifice of the animals. This inves-
tigation is presently under way.
In summary, hearts of rats submit-
ted to volume overload consequent to
aortocaval fistula creation show early
reduction of LV coronary perfusion
pressure and increased LV systolic and
end-diastolic pressure. Subsequent LV
remodeling is characterized by inter-
stitial and SE fibrosis deposition. Sub-
endocardial fibrosis was associated
with coronary perfusion pressure and
interstitial fibrosis with LV pressure.
CONCLUSIONS
Early hemodynamic changes ap-
pear to interfere with cardiac
remodeling after aortocaval fistula
creation. Impaired coronary perfusion
pressure may contribute to SE fibrosis,
and pressure overload to interstitial fi-
brosis.
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RESUMO
GUIDO MC e col. A redução da pres-
são de perfusão coronariana está
associada com a fibrose endocár-
dica no modelo de hipertrofia por
sobrecarga de volume em ratos.
Rev. Hosp. Clín. Fac. Med. S. Pau-
lo 59(4):228-235, 2004.
No remodelamento que se segue às
sobrecargas de volume não é descrito
o aumento de fibrose miocárdica. Após
o infarto, entretanto, há hipertrofia do
miocárdio remoto com acúmulo de
fibrose, particularmente no subendo-
cárdio. Na fístula aorto-cava, tal como
no infarto, é possível que a queda da
pressão de perfusão coronariana inter-
fira com a fibrose cardíaca.
OBJETIVO: Investigar o papel das
mudanças hemodinâmicas agudas sobre
a fibrose cardíaca na fístula aorto-cava.
MÉTODO: Ratos Wistar submeti-
dos a fístula aorto-cava, seguidos por
4 e 8 semanas, constituíram 4 grupos,
fístula aorto-cava 4 e fístula aorto-cava
8 (10 ratos cada) e seus respectivos
controles (sham-operated controls -
Sh), Sh4 e Sh8 (8 ratos cada). A
hemodinâmica foi realizada 1 semana
após a cirurgia. A hipertrofia e a fibrose
foram quantificadas ao final do segui-
mento pelo diâmetro dos miócitos e
pela fração de volume do colágeno.
RESULTADOS: Comparados com
Sh4 e Sh8, a pressão de pulso, a pres-
são diastólica final do ventrículo es-
querdo e a +dP/dt
 
foram maiores em
fístula aorto-cava 4 e fístula aorto-cava
8, enquanto a -dP/dt foi similar. A pres-
são estimada da perfusão coronariana
(mmHg) foi menor em fístula aorto-
cava 8 (52,6±4,1) do que em Sh8
(100,8±1,3), mas comparável entre
fístula aorto-cava 4 (50,0±8,9) e Sh4
(84,8±2,3). O diâmetro dos miócitos foi
maior em fístula aorto-cava 8 e a
fibrose intersticial e subendocárdica
maior em fístula aorto-cava 4 e fístula
aorto-cava 8. Houve correlação inver-
sa e independente da pressão de
perfusão coronariana com a fibrose
subendocárdica (r2=0,86; p<0,0001) e
das pressões sistólica (r2=0,73;
p=0,0035) e diastólica final do
ventrículo esquerdo (r2=0,55;
p=0.0124) com a fibrose intersticial.
CONCLUSÃO: A queda precoce
da pressão de perfusão coronariana e
o aumento das pressões ventriculares
após a fístula aorto-cava associam-se
com fibrose miocárdica subseqüente.
UNITERMOS: Fibrose miocár-
dica. Fístula aorto-cava. Pressão de
perfusão coronariana. Sobrecarga de
volume. Remodelamento cardíaco.
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